The Effects Of Polymers And Permeation Enhancers On Releases Of Flurbiprofen From Gel Formulations

Abstract

This risk score discriminates well between recurrent ovarian cancer patients under low, medium and high risk of short-term mortality. It may help to identify a risk group under high risk for short-term mortality that can be used for randomization in clinical trials and may support decision making for palliative chemotherapy.